
Align Technology (ALGN) Stock Forecast & Price Target
Align Technology (ALGN) Analyst Ratings
Bulls say
Align Technology is the leading manufacturer of clear aligners, which treat over 90% of all malocclusion cases and have treated over 14 million patients since launch. The global market for clear aligners appears under-penetrated, and Invisalign's rate of share losses is not accelerating, making it a sound investment for the future. Management's guidance of MSD case volume growth and +3-4% revenue growth in 2026 is reasonable and can lead to continued positive trends for the stock.
Bears say
Align Technology is expecting a modest revenue growth of +3-4% y/y for 2026 with an expectation for aligner volumes to grow MSD. They also predict a 100bp y/y expansion in OM%. Although their 2026 guidance is consistent with expectations, the 4Q international strength could potentially lead to modest upside.
This aggregate rating is based on analysts' research of Align Technology and is not a guaranteed prediction by Public.com or investment advice.
Align Technology (ALGN) Analyst Forecast & Price Prediction
Start investing in Align Technology (ALGN)
Order type
Buy in
Order amount
Est. shares
0 shares